TY  - GEN
AU  - Estey,E
AU  - Plunkett,W
AU  - Gandhi,V
AU  - Rios,M B
AU  - Kantarjian,H
AU  - Keating,M J
TI  - Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia
SN  - 1042-8194
PY  - 1993///0915
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Bone Marrow Diseases
KW  - chemically induced
KW  - Bone Marrow Transplantation
KW  - Colitis
KW  - Combined Modality Therapy
KW  - Conjunctivitis
KW  - Cytarabine
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Pancreatitis
KW  - Peripheral Nervous System Diseases
KW  - Remission Induction
KW  - Salvage Therapy
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.3109/10428199309148532
ER  -